Enlivex Therapeutics Ltd has commenced dosing for the initial two patients in its Phase III trial evaluating AllocetraTM for moderate to severe knee osteoarthritis This multicountry trial aims

OSR Holdings a significant global healthcare holding company has recently announced the signing of a memorandum of understanding with SillaJen a biotech firm listed on Kosdaq and renowned for its pipeline

BGI Genomics a renowned leader in precision medicine solutions has launched a cuttingedge clinical laboratory in Uruguays Parque de las Ciencias free trade zone This move is poised to advance preventive

ProQR Therapeutics NV has once again successfully defended a crucial patent for its groundbreaking RNA editing platform Axiomer This achievement follows the companys victory in fending off opposition against its key patent EP B filed with the European Patent Office

Tiziana Life Sciences Ltd recently announced a significant development regarding its lead candidate foralumab in a study highlighted by Neurology Today the official news source of the American Academy

Vertex Pharmaceuticals Incorporated has unveiled significant progress in its suzetrigine pain program potentially marking a breakthrough in acute and neuropathic pain treatment Suzetrigine an oral selective

Innocan Pharma Corporation is pleased to announce that is has reached a key milestone the Company submitted its letter of application for a PreIND meeting

Lantern Pharma Inc an artificial intelligence company developing targeted and transformative cancer therapies using its proprietary RADR AI and machine learning

Bristol Myers Squibb and Cellares the first Integrated Development and Manufacturing Organization

Kynos Therapeutics Ltd a clinical stage biotechnology company developing firstinclass small molecule

The convention will commence with opening speeches from the Minister of Science and Technology in Vietnam followed by Daniel Shi the Project Director of analytica Vietnam from the event organizer MMI

Kintor Pharmaceutical Limited a clinicalstage biotechnology company developing innovative small molecules and biological therapeutics announced that the China phase II clinical trial of its inhouse developed firstinclass androgen receptor